Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone Extension Study in DMD
NCT00758225Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Primary endpoints: Nature and frequency of Adverse Events, Laboratory parameters (haematology, biochemistry and urinalysis) and 2 more. Started Sep 2008; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00758225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758225.